The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-(6-Fluoro-5-methylpyridin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)[1,2,4]triazolo[4,3-a]quinoxaline ID: ALA4865476
PubChem CID: 164623221
Max Phase: Preclinical
Molecular Formula: C20H18FN5O
Molecular Weight: 363.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)cnc1F
Standard InChI: InChI=1S/C20H18FN5O/c1-12-8-15(10-23-19(12)21)14-2-3-16-17(9-14)26-18(11-22-16)24-25-20(26)13-4-6-27-7-5-13/h2-3,8-11,13H,4-7H2,1H3
Standard InChI Key: KEKDSRDEIVDHBR-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
23.3216 -27.6194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3204 -28.4430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0326 -28.8561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0308 -27.2105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7435 -27.6158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7443 -28.4389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4570 -28.8501 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.1693 -28.4352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4514 -27.2055 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.1636 -27.6060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7633 -27.0522 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.4258 -26.3120 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.6135 -26.4043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0571 -25.8007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3090 -25.0169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7565 -24.4117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9534 -24.5846 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.7056 -25.3685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2569 -25.9794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6117 -27.2111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6128 -26.3887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9017 -25.9762 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1931 -26.3892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1960 -27.2147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9035 -27.6194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4898 -27.6260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4839 -25.9832 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 10 1 0
9 5 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 9 1 0
14 15 1 0
14 19 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
13 14 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
1 20 1 0
24 26 1 0
23 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 363.40Molecular Weight (Monoisotopic): 363.1495AlogP: 3.68#Rotatable Bonds: 2Polar Surface Area: 65.20Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.00CX LogP: 2.01CX LogD: 2.01Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.51Np Likeness Score: -1.32
References 1. Berger M, Wortmann L, Buchgraber P, Lücking U, Zitzmann-Kolbe S, Wengner AM, Bader B, Bömer U, Briem H, Eis K, Rehwinkel H, Bartels F, Moosmayer D, Eberspächer U, Lienau P, Hammer S, Schatz CA, Wang Q, Wang Q, Mumberg D, Nising CF, Siemeister G.. (2021) BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies., 64 (17.0): [PMID:34428039 ] [10.1021/acs.jmedchem.1c00762 ]